Syntal Capital Partners, LLC Abbott Laboratories Transaction History

Syntal Capital Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $1.94 Million - $2.11 Million	-23,757 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $447,410 - $521,815	-6,139 Reduced 20.53%	23,757 $2 Million
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $54,300 - $65,649	820 Added 2.82%	29,896 $2.39 Million
Q4 2018 Feb 13, 2019	SELL	$65.56 - $74.27 $122,203 - $138,439	-1,864 Reduced 6.02%	29,076 $2.1 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $1.88 Million - $2.27 Million	30,940 New	30,940 $2.27 Million

3,224

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $224B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Syntal Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Syntal Capital Partners, LLC with notifications on news.